Detalhe da pesquisa
1.
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study.
Blood
; 139(21): 3148-3158, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303070
2.
A two-part, single-arm, multicentre, phase I study of zanubrutinib, a selective Bruton tyrosine kinase inhibitor, in Chinese patients with relapsed/refractory B-cell malignancies.
Br J Haematol
; 198(1): 62-72, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383885
3.
Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer.
Gynecol Oncol
; 157(3): 765-774, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192732
4.
IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.
Int J Mol Sci
; 20(11)2019 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31212584
5.
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Blood Adv
; 8(7): 1639-1650, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315878
6.
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia.
Clin Cancer Res
; 27(20): 5492-5501, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253577
7.
"Five-point eight-line" anatomic flap design for precise hemitongue reconstruction.
Head Neck
; 41(5): 1359-1366, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561069
8.
Novel ANO5 mutation c.1067G>T (p.C356F) identified by whole genome sequencing in a big family with atypical gnathodiaphyseal dysplasia.
Head Neck
; 41(1): 230-238, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30554457
9.
SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression.
Cell Prolif
; 51(5): e12484, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30039889
10.
The Use of a Honeycomb Technique Combined with Ultrasonic Aspirators and Indocyanine Green Fluorescence Angiography for a Superthin Anterolateral Thigh Flap: A Pilot Study.
Plast Reconstr Surg
; 141(6): 902e-910e, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742652
11.
Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis.
Leuk Lymphoma
; 64(3): 712-716, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799536
12.
Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation.
Oncotarget
; 7(44): 71466-71476, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27683116
13.
Chromatin accessibility contributes to simultaneous mutations of cancer genes.
Sci Rep
; 6: 35270, 2016 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27762310
14.
Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
Oncotarget
; 7(6): 6847-63, 2016 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26760772
15.
Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma.
Cancer Lett
; 337(1): 96-106, 2013 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23693078
16.
Deficiency of IRTKS as an adaptor of insulin receptor leads to insulin resistance.
Cell Res
; 23(11): 1310-21, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23896986